Neoadjuvant Chemoimmunotherapy Does Not Increase Postoperative Morbidity of Pneumonectomy in NSCLC Patients: A Multi-Center Psmanalysis

被引：0
|
作者：
Li, Z. [1 ]
He, W. [1 ]
机构：
[1] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
pneumonectomy; non-small cell lung cancer; Neoadjuvant chemoimmunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.08D.06
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [31] Performing Omentectomy During Gastrectomy Does Not Improve Survival: a Multi-Center Analysis of 471 Patients with Gastric Adenocarcinoma
    Young, Stephanie
    DiFronzo, L. Andrew
    Ahuja, Ashim
    Keim, Lauren
    Papenfuss, Curtis
    O'Connor, Victoria
    Dehal, Ahmed
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (12) : 2856 - 2858
  • [32] Radiomics nomogram for the prediction of microvascular invasion of HCC and patients’ benefit from postoperative adjuvant TACE: a multi-center study
    Kun Zhang
    Lei Zhang
    Wen-Cui Li
    Shuang-Shuang Xie
    Ying-Zhu Cui
    Li-Ying Lin
    Zhi-Wei Shen
    Hui-Mao Zhang
    Shuang Xia
    Zhao-Xiang Ye
    Kan He
    Wen Shen
    European Radiology, 2023, 33 : 8936 - 8947
  • [33] Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
    Li, Weihao
    Li, Xinyue
    Yu, Kun
    Xiao, Binyi
    Peng, Jianhong
    Zhang, Rongxin
    Zhang, Lingfang
    Wang, Kun
    Pan, Zhizhong
    Li, Cong
    Wu, Xiaojun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Interpretable machine learning model for early morbidity risk prediction in patients with sepsis-induced coagulopathy: a multi-center study
    Tan, Ruimin
    Ge, Chen
    Wang, Jingmei
    Yang, Zinan
    Guo, He
    Yan, Yating
    Du, Quansheng
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [35] Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
    Chongwu Li
    Junqi Wu
    Long Jiang
    Lei Zhang
    Jia Huang
    Yu Tian
    Yue Zhao
    Xiucheng Liu
    Lang Xia
    Haoran E
    Peigen Gao
    Likun Hou
    Minglei Yang
    Minjie Ma
    Chunxia Su
    Hao Zhang
    Hezhong Chen
    Yunlang She
    Dong Xie
    Qingquan Luo
    Chang Chen
    Cancer Immunology, Immunotherapy, 2023, 72 : 795 - 795
  • [36] Study Design of SCORPION: Multi-Center, Phase II Study Following Platinum-Based Chemotherapy Plus ICIs in Patients with NSCLC
    Matsuzawa, R.
    Morise, M.
    Ito, K.
    Hataji, O.
    Takahashi, K.
    Hara, T.
    Goto, Y.
    Imaizumi, K.
    Itani, H.
    Yamaguchi, T.
    Zenke, Y.
    Oki, M.
    Kogure, Y.
    Hashimoto, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1102 - S1103
  • [37] The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational study
    Singer, Susanne
    Semrau, Sabine
    Golcher, Henriette
    Fechner, Katja
    Kallies, Annett
    Bonilla, Sergio Zapata
    Gruetzmann, Robert
    Fietkau, Rainer
    Kluba, Torsten
    Jentsch, Christina
    Andreou, Dimosthenis
    Bornhaeuser, Martin
    Schmitt, Jochen
    Schuler, Markus K.
    Eichler, Martin
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [38] DOES THE PRESENCE OF ROBOTIC SURGERY AFFECT DEMOGRAPHICS IN PATIENTS CHOOSING TO UNDERGO RADICAL PROSTATECTOMY? A MULTI-CENTER CONTEMPORARY ANALYSIS
    Cheetham, P.
    Lee, D.
    Brewster, S.
    Truesdale, M.
    Badani, K.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A131 - A131
  • [39] Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis
    Cheetham P.J.
    Lee D.J.
    Rose-Morris A.
    Brewster S.F.
    Badani K.K.
    Journal of Robotic Surgery, 2010, 4 (3) : 155 - 160
  • [40] A multi-center phase II study of toripalimab with chemotherapy in patients with EGFR mutant advanced NSCLC patients resistant to EGFR TKIs: Efficacy and biomarker analysis.
    Ren, Shengxiang
    Zhang, Jie
    Zhao, Yanqiu
    Mu, Xiaoqian
    Zhou, Jianying
    Bao, Zhang
    Fan, Yun
    Xu, Yanjun
    Shu, Yongqian
    Guo, Renhua
    Liu, Xiaoqing
    Wang, Hong
    Zhang, Helong
    Deng, Lin
    Ma, Ningqiang
    He, Jianxing
    Zhang, Yalei
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345